Association of metabolic syndrome and chronic kidney disease
Open accessAbstract
The prevalence of kidney disease is increasing rapidly worldwide, reflecting rising rates of obesity, diabetes, and associated metabolic syndrome (MetS). Chronic kidney disease and related comorbidities such as obesity, diabetes, and hypertension place a significant financial burden on healthcare systems. Despite the widespread use of RAAS inhibitors, intensive blood pressure and glycemic control, and newer therapeutic options consisting of sodium/glucose cotransporter-2 (SGLT-2) inhibitors or glucagon-like peptide-1 (GLP-1) receptor agonists, a significant risk of progression to end-stage renal disease remains in the high-risk obese and diabetic population. The MetS is a cluster of cardiovascular risk factors that adversely affect the development and progression of chronic kidney failure. According to the criteria of the World Health Organization, it is defined by visceral adiposity, impaired glucose tolerance or insulin resistance, atherogenic dyslipidemia, raised blood pressure, and microalbuminuria with a albumin-to-creatinine ratio ≥30 mg/g. At molecular level MetS is marked by a proinflammatory state and increased oxidative stress leading to various pathophysiological changes causing endothelial dysfunction and a hypercoagulable state. Because the kidney is a highly vascularized organ, it is especially susceptible for those microvascular changes. Therefore, the MetS and its individual components are associated with the premature development, acceleration, and progressio…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cardioprotective properties of EPA that offset inflammation and oxidative stress while improving endothelial function may have been operative in this high-risk phenotype.
“Although the study was not designed to examine mechanism(s) underlying CVD risk reduction in CKM, cardioprotective properties of EPA that offset inflammation and oxidative stress while improving endothelial function may have been operative in this high-risk phenotype [[15], [16], [17], [18]].”
From Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM (2026) · cites this paper as [17]
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860 · see citing works
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286 · see citing works
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · see citing works
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140 · see citing works
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382 · see citing works
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189 · see citing works
Dapagliflozin in Patients with Chronic Kidney Disease
Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024816 · Cited by 5,618 · see citing works
Cardiovascular and renal outcomes with empagliflozin in heart failure
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022190 · Cited by 5,206 · see citing works
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472 · see citing works
Tirzepatide Once Weekly for the Treatment of Obesity
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206038 · Cited by 3,838 · cited 1× · see citing works
“45,150,151 Thereby, reduction in the liver, visceral, and subcutaneous fat contents have been observed.”
BackgroundBanting lecture 1988. Role of insulin resistance in human disease.
Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801 · see citing works
Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
Bakris, G. L., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, P., Kolkhof, P., Nowack, C., Schloemer, P., Joseph, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2025845 · Cited by 2,935 · cited 1× · see citing works
“81 In animal models, finerenone was able to oppose MetS-associated cardiac dysfunction and nephropathy.”
BackgroundEmpagliflozin in Patients with Chronic Kidney Disease
The EMPA-KIDNEY Collaborative Group (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2204233 · Cited by 2,754 · cited 1× · see citing works
“…objected to the same limitations as metformin: SGLT2i should not be administered in patients with eGFR 20 ml/min/1.73 m 2 and GLP-1R agonists in those with eGFR 15 ml/min/1.73 153 The detailed presentation of the many pleiotropic actions of these drug classes are beyond the scope of this review.”
BackgroundInfluentialComment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820 · see citing works
Gut microbial metabolites in obesity, NAFLD and T2DM
Canfora, E. E., Meex, R. C. R., Venema, K., & Blaak, E. E. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0156-z · Cited by 1,493 · see citing works
Javaheri, S., Barbe, F., Campos-Rodriguez, F., Dempsey, J. A., Khayat, R., Javaheri, S., Malhotra, A., Martinez-Garcia, M. A., Mehra, R., Pack, A. I., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.069 · Cited by 1,434 · see citing works
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373 · see citing works
Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305697 · Cited by 1,360 · see citing works
Salt-responsive gut commensal modulates TH17 axis and disease
Wilck, N., Matus, M. G., Kearney, S. M., Olesen, S. W., Forslund, K., Bartolomaeus, H., Haase, S., Mähler, A., Balogh, A., Markó, L., et al. (2017) · Nature · doi:10.1038/nature24628 · Cited by 1,310 · see citing works
Obesity-related glomerulopathy: An emerging epidemic
Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J., & D’Agati, V. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041498.x · Cited by 1,279 · see citing works
Obesity, Weight Gain, and the Risk of Kidney Stones
Taylor, E. N. (2005) · JAMA · doi:10.1001/jama.293.4.455 · Cited by 1,193 · see citing works
Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163 · see citing works
Khan, S. R., Pearle, M. S., Robertson, W., Gambaro, G., Canales, B. K., Doizi, S., Traxer, O., & Tiselius, H. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.8 · Cited by 1,103 · see citing works
Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016
Hirode, G., & Wong, R. J. (2020) · JAMA · doi:10.1001/jama.2020.4501 · Cited by 936 · see citing works
Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Bommel, E. J., Heerspink, H. J. L., van Raalte, D. H., & Joles, J. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060666 · Cited by 887 · see citing works
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · Cited by 852 · see citing works
Kaplan, N. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390070054005 · Cited by 842 · see citing works
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753 · see citing works
Once-weekly semaglutide in adolescents with obesity
Weghuber, D., Barrett, T., Barrientos-Pérez, M., Gies, I., Hesse, D., Jeppesen, O. K., Kelly, A. S., Mastrandrea, L. D., Sørrig, R., & Arslanian, S. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2208601 · Cited by 730 · see citing works
Obesity Pathogenesis: An Endocrine Society Scientific Statement
Schwartz, M. W., Seeley, R. J., Zeltser, L. M., Drewnowski, A., Ravussin, E., Redman, L. M., & Leibel, R. L. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00111 · Cited by 727 · cited 1× · see citing works
“135 However, the recurrence rate is high, 136 and many patients are unable to maintain sufficient weight loss to significantly reduce their risk for cardiometabolic and renal disease.”
BackgroundThe National Cholesterol Education Program
Cleeman, J. I. (1989) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30638-3 · Cited by 711 · see citing works
Obesity, kidney dysfunction and hypertension: mechanistic links
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654 · see citing works
Tuttle, K. R., Lakshmanan, M. C., Rayner, B., Busch, R. S., Zimmermann, A. G., Woodward, D. B., & Botros, F. T. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30104-9 · Cited by 648 · see citing works
NAFLD as a Continuum: From Obesity to Metabolic Syndrome and Diabetes
Godoy-Matos, A. F., Silva Júnior, W. S., & Valerio, C. M. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00570-y · Cited by 643 · see citing works
Hypertension in CKD: Core Curriculum 2019
Ku, E., Lee, B. J., Wei, J., & Weir, M. R. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.12.044 · Cited by 582 · see citing works
Abate, N. I., Chandalia, M., Cabo-Chan, A. V., Moe, O. W., & Sakhaee, K. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00386.x · Cited by 558 · see citing works
Leoni, S., Tovoli, F., Napoli, L., Serio, I., Ferri, S., & Bolondi, L. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i30.3361 · Cited by 542 · see citing works
The Effects of Weight Loss on Renal Function in Patients with Severe Obesity
Chagnac, A., Weinstein, T., Herman, M., Hirsh, J., Gafter, U., & Ori, Y. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068462.38661.89 · Cited by 537 · see citing works
Hypertension-Linked Pathophysiological Alterations in the Gut
Santisteban, M. M., Qi, Y., Zubcevic, J., Kim, S., Yang, T., Shenoy, V., Cole-Jeffrey, C. T., Lobaton, G. O., Stewart, D. C., Rubiano, A., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.309006 · Cited by 525 · see citing works
Shibata, S., Nagase, M., Yoshida, S., Kawarazaki, W., Kurihara, H., Tanaka, H., Miyoshi, J., Takai, Y., & Fujita, T. (2008) · Nature Medicine · doi:10.1038/nm.1879 · Cited by 463 · see citing works
NAFLD as a driver of chronic kidney disease
Byrne, C. D., & Targher, G. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.013 · Cited by 449 · see citing works
Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity
Unger, R. H., & Scherer, P. E. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.01.009 · Cited by 436 · see citing works
Angeli, P., García–Tsao, G., Nadim, M. K., & Parikh, C. R. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.07.002 · Cited by 435 · see citing works
Shimizu, M., Suzuki, K., Kato, K., Jojima, T., Iijima, T., Murohisa, T., Iijima, M., Takekawa, H., Usui, I., Hiraishi, H., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13520 · Cited by 393 · see citing works
Huby, A.-C., Antonova, G., Groenendyk, J., Gomez-Sanchez, C. E., Bollag, W. B., Filosa, J. A., & de Chantemèle, E. J. B. (2015) · Circulation · doi:10.1161/circulationaha.115.018226 · Cited by 376 · see citing works
Garofalo, C., Borrelli, S., Minutolo, R., Chiodini, P., De Nicola, L., & Conte, G. (2017) · Kidney International · doi:10.1016/j.kint.2016.12.013 · Cited by 363 · see citing works
Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort
Havulinna, A. S., Sysi‐Aho, M., Hilvo, M., Kauhanen, D., Hurme, R., Ekroos, K., Salomaa, V. V., & Laaksonen, R. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307497 · Cited by 345 · see citing works
Stojsavljević, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i48.18070 · Cited by 325 · see citing works
Role of insulin resistance in human disease
Reaven, G. M. (1997) · Nutrition · doi:10.1016/s0899-9007(96)00380-2 · Cited by 320 · see citing works
The Nephrotic Syndrome: A Complication of Massive Obesity
Weisinger, J. R., Kempson, R. L., Eldridge, F. L., & Swenson, R. S. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-440 · Cited by 318 · see citing works
The Modern Spectrum of Renal Biopsy Findings in Patients with Diabetes
Sharma, S. G., Bomback, A. S., Radhakrishnan, J., Herlitz, L., Stokes, M. B., Markowitz, G. S., & D’Agati, V. D. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02510213 · Cited by 313 · see citing works
Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy
Manno, C., Strippoli, G. F., Arnesano, L., Bonifati, C., Campobasso, N., Gesualdo, L., & Schena, F. P. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00922.x · Cited by 308 · see citing works
Boon, J., Hoy, A. J., Stark, R., Brown, R. D., Meex, R. C. R., Henstridge, D. C., Schenk, S., Meikle, P. J., Horowitz, J. F., Kingwell, B. A., et al. (2012) · Diabetes · doi:10.2337/db12-0686 · Cited by 304 · see citing works
Noubiap, J. J., Nansseu, J. R., Lontchi-Yimagou, E., Nkeck, J. R., Nyaga, U. F., Ngouo, A. T., Tounouga, D. N., Tianyi, F. L., Foka, A. J., Ndoadoumgue, A. L., et al. (2022) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00374-6 · Cited by 304 · see citing works
Metabolic syndrome and chronic kidney disease
Singh, A. K., & Kari, J. A. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32835dda78 · Cited by 299 · see citing works
Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism
Bertolio, R., Napoletano, F., Mano, M., Maurer‐Stroh, S., Fantuz, M., Zannini, A., Bicciato, S., Sorrentino, G., & Sal, G. D. (2019) · Nature Communications · doi:10.1038/s41467-019-09152-7 · Cited by 296 · see citing works
Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5
Kushner, R. F., Calanna, S., Davies, M., Dicker, D., Garvey, W. T., Goldman, B., Lingvay, I., Thomsen, M., Wadden, T. A., Wharton, S., et al. (2020) · Obesity · doi:10.1002/oby.22794 · Cited by 288 · see citing works
Kidney Stones 2012: Pathogenesis, Diagnosis, and Management
Sakhaee, K., Maalouf, N. M., & Sinnott, B. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3492 · Cited by 284 · see citing works
Metabolic Syndrome and Risk of Acute Myocardial Infarction
Mente, A., Yusuf, S., Islam, S., McQueen, M., Tanomsup, S., Onen, C. L., Rangarajan, S., Gerstein, H. C., & Anand, S. S. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.053 · Cited by 261 · see citing works
Noubiap, J. J., Nansseu, J. R., Lontchi‐Yimagou, E., Nkeck, J. R., Nyaga, U. F., Ngouo, A. T., Tounouga, D. N., Tianyi, F., Foka, A. J., Ndoadoumgue, A. L., et al. (2022) · LSTM Online Archive (Liverpool School of Tropical Medicine) · Cited by 254 · see citing works
Systematic Review and Meta-Analysis of Native Kidney Biopsy Complications
Poggio, E. D., McClelland, R. L., Blank, K. N., Hansen, S. L., Bansal, S., Bomback, A. S., Canetta, P. A., Khairallah, P., Kiryluk, K., Lecker, S. H., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04710420 · Cited by 252 · see citing works
Talbott, J. H., & TERPLAN, K. L. (1960) · Medicine · doi:10.1097/00005792-196012000-00001 · Cited by 252 · see citing works
Zimmet, P., Boyko, E. J., Collier, G. R., & de Courten, M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07783.x · Cited by 233 · see citing works
Targher, G., Bertolini, L., Rodella, S., Lippi, G., Zoppini, G., & Chonchol, M. (2010) · American Society of Nephrology. Clinical Journal · doi:10.2215/cjn.05050610 · Cited by 229 · see citing works
Protection of the kidney by thiazolidinediones: An assessment from bench to bedside
Sarafidis, P. A., & Bakris, G. L. (2006) · Kidney International · doi:10.1038/sj.ki.5001620 · Cited by 221 · see citing works
Obesity and Cardiac Remodeling in Adults: Mechanisms and Clinical Implications
Alpert, M. A., Karthikeyan, K., Abdullah, O., & Ghadban, R. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.07.012 · Cited by 221 · see citing works
Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
Królewski, A. S. (2015) · Diabetes Care · doi:10.2337/dc15-0184 · Cited by 219 · see citing works
Management of cardiovascular diseases in patients with obesity
Lavie, C. J., Arena, R., Alpert, M. A., Milani, R. V., & Ventura, H. O. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.108 · Cited by 218 · see citing works
Chronic Kidney Disease in Kidney Stone Formers
Rule, A. D., Krambeck, A. E., & Lieske, J. C. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10651110 · Cited by 217 · see citing works
Cortinovis, M., Perico, N., Ruggenenti, P., Remuzzi, A., & Remuzzi, G. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00559-y · Cited by 214 · see citing works
Reisinger, C., Nkeh-Chungag, B. N., Fredriksen, P. M., & Goswami, N. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00713-1 · Cited by 213 · see citing works
Sleep Apnea and Cardiovascular Disease: An Enigmatic Risk Factor
Floras, J. S. (2018) · Circulation Research · doi:10.1161/circresaha.118.310783 · Cited by 209 · see citing works
Oxalate Nephropathy Complicating Roux-en-Y Gastric Bypass
Nasr, S. H., D’Agati, V. D., Said, S. M., Stokes, M. B., Largoza, M. V., Radhakrishnan, J., & Markowitz, G. S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02940608 · Cited by 201 · see citing works
Immunologic and endocrine functions of adipose tissue: implications for kidney disease
Zhu, Q., & Scherer, P. E. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.157 · Cited by 200 · see citing works
Uric acid and inflammation in kidney disease
Jung, S. W., Kim, S.-M., Kim, Y., Lee, S. H., & Moon, J.-Y. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00272.2019 · Cited by 196 · see citing works
Bray, J. J. H., Foster‐Davies, H., Salem, A., Hoole, A. L., Obaid, D. R., Halcox, J. P. J., & Stephens, J. W. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14399 · Cited by 194 · see citing works
Jones, D. W., Kim, J. S., Andrew, M. E., Kim, S. J., & Hong, Y. P. (1994) · Journal of Hypertension · doi:10.1097/00004872-199412000-00018 · Cited by 191 · see citing works
Barrera-Chimal, J., Estrela, G. R., Lechner, S. M., Giraud, S., El Moghrabi, S., Kaaki, S., Kolkhof, P., Hauet, T., & Jaisser, F. (2018) · Kidney International · doi:10.1016/j.kint.2017.12.016 · Cited by 183 · see citing works
The metabolic syndrome and chronic kidney disease
Zhang, X., & Lerman, L. O. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.004 · Cited by 177 · see citing works
The Renin Angiotensin Aldosterone System in Obesity and Hypertension
Cabandugama, P. K., Gardner, M. J., & Sowers, J. R. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.009 · Cited by 168 · see citing works
Metabolic syndrome and chronic kidney disease: Current status and future directions
Prasad, G. V. R. (2014) · World Journal of Nephrology · doi:10.5527/wjn.v3.i4.210 · Cited by 164 · see citing works
Metformin improves endothelial function in patients with metabolic syndrome
VITALE, C., MERCURO, G., CORNOLDI, A., FINI, M., VOLTERRANI, M., & ROSANO, G. M. C. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01531.x · Cited by 164 · see citing works
The Association of Increasing Body Mass Index and Kidney Stone Disease
Semins, M. J., Shore, A. D., Makary, M. A., Magnuson, T. H., Johns, R. A., & Matlaga, B. R. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.09.085 · Cited by 160 · see citing works
Renal Dysfunction, Rather Than Nonrenal Vascular Dysfunction, Mediates Salt-Induced Hypertension
Hall, J. E. (2016) · Circulation · doi:10.1161/circulationaha.115.018526 · Cited by 152 · see citing works
Sellmayr, M., Petzsche, M. R. H., Ma, Q., Krüger, N., Liapis, H., Brink, A., Lenz, B. F., Angelotti, M. L., Gnemmi, V., Kuppe, C., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040523 · Cited by 147 · see citing works
Long-term Morbidity Following Jejunoileal Bypass
Requarth, J. A. (1995) · Archives of Surgery · doi:10.1001/archsurg.1995.01430030088018 · Cited by 145 · see citing works
Metabolic syndrome-related kidney injury: a review and update
Lin, L., Tan, W., Pan, X., Tian, E., Wu, Z., & Yang, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.904001 · Cited by 139 · see citing works
Lopes, H. F., Corrêa‐Giannella, M. L., Consolim‐Colombo, F. M., & Egan, B. M. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0156-2 · Cited by 139 · see citing works
Whaley‐Connell, A. T., & Sowers, J. R. (2017) · Kidney International · doi:10.1016/j.kint.2016.12.034 · Cited by 137 · see citing works
Pathophysiology and Management of Hyperoxaluria and Oxalate Nephropathy: A Review
Demoulin, N., Aydın, S., Gillion, V., Morelle, J., & Jadoul, M. Y. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.07.018 · Cited by 136 · see citing works
Xia, M., Bian, H., & Gao, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00877 · Cited by 133 · see citing works
Characteristics of healthy vascular ageing in pooled population-based cohort studies
Nilsson, P. M., Laurent, S., Cunha, P., Olsen, M. H., Rietzschel, E. R., Franco, O. H., Ryliškytė, L., Strazhesko, I. D., Vlachopoulos, C. V., Chen, C., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001824 · Cited by 132 · see citing works
Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis
Velez, J. C. Q., Therapondos, G., & Juncos, L. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0218-4 · Cited by 131 · see citing works
Mineralocorticoid Receptor Activation Promotes Vascular Cell Calcification
Jaffe, I. Z., Tintut, Y., Newfell, B. G., Demer, L. L., & Mendelsohn, M. E. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000258414.59393.89 · Cited by 129 · see citing works
Diabetic eNOS knockout mice develop distinct macro- and microvascular complications
Mohan, S., Reddick, R. L., Musi, N., Horn, D. A., Yan, B., Prihoda, T. J., Natarajan, M., & Abboud‐Werner, S. L. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.23 · Cited by 127 · see citing works
Metabolic syndrome and stroke: A meta-analysis of prospective cohort studies
Li, X., Li, X., Lin, H., Fu, X., Lin, W., Li, M., Zeng, X., & Gao, Q. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.01.018 · Cited by 125 · see citing works
Straznicky, N. E., Grima, M. T., Lambert, É., Eikelis, N., Dawood, T., Lambert, G. W., Nestel, P. J., Masuo, K., Sari, C. I., Chopra, R., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283418875 · Cited by 123 · see citing works
Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?
Davenport, A., Sheikh, M., Lamb, E. J., Agarwal, B., & Jalan, R. (2017) · Kidney International · doi:10.1016/j.kint.2017.04.048 · Cited by 115 · see citing works
Urbanet, R., Nguyen Dinh Cat, A., Feraco, A., Venteclef, N., El Mogrhabi, S., Sierra-Ramos, C., Alvarez de la Rosa, D., Adler, G. K., Quilliot, D., Rossignol, P., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04981 · Cited by 114 · see citing works
Chemoreflexes, Sleep Apnea, and Sympathetic Dysregulation
Mansukhani, M. P., Kara, T., Caples, S. M., & Somers, V. K. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0476-2 · Cited by 112 · see citing works
Phrueksotsai, S., Pinyopornpanish, K., Euathrongchit, J., Leerapun, A., Phrommintikul, A., Buranapin, S., Chattipakorn, N., & Thongsawat, S. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15580 · Cited by 104 · see citing works
Accuracy of GFR estimation in obese patients.
Lemoine, S., Guebre-Egziabher, F., Sens, F., Nguyen-Tu, M.-S., Juillard, L., Dubourg, L., & Hadj-Aissa, A. (2014) · American Society of Nephrology. Clinical Journal · doi:10.2215/cjn.03610413 · Cited by 103 · see citing works
Adipocytes, aldosterone and obesity-related hypertension
Cat, A. N. D., Friederich‐Persson, M., White, A. D., & Touyz, R. M. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0025 · Cited by 96 · see citing works
Butler, M. J., Ramnath, R. D., Kadoya, H., Desposito, D., Riquier‐Brison, A., Ferguson, J., Onions, K. L., Ogier, A. S., Elhegni, H. E., Coward, R. J., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.08.024 · Cited by 94 · see citing works
Obesity and chronic kidney disease
Nehus, E. J. (2018) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000586 · Cited by 84 · see citing works
Jinjuvadia, R., Antaki, F., Lohia, P., & Liangpunsakul, S. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000666 · Cited by 82 · see citing works
Early histological changes in the kidney of people with morbid obesity
Goumenos, D. S., Kawar, B., Nahas, M. E., Conti, S., Wagner, B. E., Spyropoulos, C., Vlachojannis, J. G., Benigni, A., & Kalfarentzos, F. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp329 · Cited by 82 · see citing works
Bloomgarden, Z. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1297 · Cited by 81 · see citing works
Renal Biopsy in Type 2 Diabetic Patients
Espinel, E., Agraz, I., Ibernón, M., Ramos-Terrades, N., Fort, J., & Serón, D. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4050998 · Cited by 78 · see citing works
Kouvari, M., Chrysohoou, C., Skoumas, J., Pitsavos, C., Panagiotakos, D. B., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2021.154893 · Cited by 74 · see citing works
The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
Steenbeke, M., Speeckaert, R., Desmedt, S., Glorieux, G., Delanghe, J., & Speeckaert, M. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073439 · Cited by 73 · see citing works
Adeosun, S. O., Gordon, D. M., Weeks, M. F., Moore, K. H., Hall, J. E., Hinds, T. D., & Stec, D. E. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00495.2017 · Cited by 73 · see citing works
Lee, T. H., Chen, J., Wu, C., Yang, C., & Yang, H. (2021) · Diagnostics · doi:10.3390/diagnostics11091674 · Cited by 73 · see citing works
Physiological role of adiponectin in different tissues: a review
Esmaili, S., Hemmati, M., & Karamian, M. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1493606 · Cited by 71 · see citing works
Rosenstock, J. L., Joab, T. M. J., DeVita, M. V., Yang, Y., Sharma, P., & Bijol, V. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab145 · Cited by 71 · see citing works
Distribution of renal medullary hyaluronan in lean and obese rabbits
Dwyer, T. M., Banks, S. A., Alonso-Galicia, M., Cockrell, K., Carroll, J. F., Bigler, S. A., & Hall, J. E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00218.x · Cited by 68 · see citing works
Bray, J. J. H., Foster-Davies, H., & Stephens, J. W. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108368 · Cited by 64 · see citing works
Georgianos, P. I., & Agarwal, R. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac124 · Cited by 61 · see citing works
Systematic review and meta-analysis: SGLT2 inhibitors, blood pressure and cardiovascular outcomes
Benham, J. L., Booth, J. E., Sigal, R. J., Daskalopoulou, S. S., Leung, A. A. C., & Rabi, D. M. (2021) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2021.100725 · Cited by 60 · see citing works
van Ruiten, C. C., Smits, M. M., Kok, M. D., Serné, E. H., van Raalte, D. H., Kramer, M. H. H., Nieuwdorp, M., & IJzerman, R. G. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01492-x · Cited by 56 · see citing works
Lachaux, M., Barrera‐Chimal, J., Nicol, L., Rémy‐Jouet, I., Renet, S., Dumesnil, A., Wecker, D., Richard, V. J., Kolkhof, P., Jaisser, F., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13393 · Cited by 54 · see citing works
Risk of chronic kidney disease in patients with kidney stones—a nationwide cohort study
Chuang, T.-F., Hung, H., Li, S., Lee, M.-W., Pai, J., & Hung, C. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01950-2 · Cited by 54 · see citing works
The spectrum of kidney biopsy findings in patients with morbid obesity
Choung, H. Y. G., Bomback, A. S., Stokes, M. B., Santoriello, D., Campenot, E. S., Batal, I., Markowitz, G. S., & D’Agati, V. D. (2019) · Kidney International · doi:10.1016/j.kint.2018.11.026 · Cited by 51 · see citing works
Adherence to a Healthy Lifestyle and All-Cause Mortality in CKD
Ricardo, A. C., Madero, M., Yang, W. P., Anderson, C. A. M., Menezes, M., Fischer, M. J., Turyk, M. E., Daviglus, M. L., & Lash, J. P. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00600112 · Cited by 49 · see citing works
The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the Kidney
Pulakat, L., DeMarco, V. G., Whaley‐Connell, A. T., & Sowers, J. R. (2011) · Cardiorenal Medicine · doi:10.1159/000327140 · Cited by 48 · see citing works
Mantovani, A., Lunardi, G., Bonapace, S., Dugo, C., Altomari, A., Molon, G., Conti, A., Bovo, C., Laaksonen, R., Byrne, C. D., et al. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.03.003 · Cited by 47 · see citing works
Yoshida, S., Ishizawa, K., Ayuzawa, N., Ueda, K., Takeuchi, M., Kawarazaki, W., Fujita, T., & Nagase, M. (2014) · Nephron Experimental Nephrology · doi:10.1159/000358758 · Cited by 45 · see citing works
The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions
Tirandi, A., Carbone, F., Montecucco, F., & Liberale, L. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13693 · Cited by 45 · see citing works
Lerma, E. V., & Wilson, D. J. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2094770 · Cited by 42 · see citing works
Endothelial Insulin and IGF-1 Receptors: When Yes Means NO
Muniyappa, R., & Sowers, J. R. (2012) · Diabetes · doi:10.2337/db12-0654 · Cited by 39 · see citing works
Metabolic syndrome and nephrolithiasis.
Ramaswamy, K. A., & Shah, O. D. (2014) · PubMed Central · doi:10.3978/j.issn.2223-4683.2014.06.03 · Cited by 38 · see citing works
Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins
Scarpioni, R. (2012) · World Journal of Nephrology · doi:10.5527/wjn.v1.i6.184 · Cited by 37 · see citing works
Effects of reactive oxygen species on renal tubular transport
Gonzalez‐Vicente, A., Hong, N. J., & Garvin, J. L. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00604.2018 · Cited by 35 · see citing works
Li, L., Yang, J., Li, F., Zhu, L., & Hao, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11872 · Cited by 34 · see citing works
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease
Ciardullo, S., Ballabeni, C., Trevisan, R., & Perseghin, G. (2021) · American Journal of Nephrology · doi:10.1159/000518111 · Cited by 34 · see citing works
Increased Hyaluronic Acid in the Inner Renal Medulla of Obese Dogs
Alonso-Galicia, M., Dwyer, T. M., Herrera, G. A., & Hall, J. E. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.888 · Cited by 32 · see citing works
Stewart, L. K., & Kline, J. A. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201907-518oc · Cited by 28 · see citing works
Diabetic nephropathy: a global and growing threat.
Tang, S. C. W. (2010) · PubMed · Cited by 26 · see citing works
Lemoine, S., Panaye, M., Pelletier, C. C., Bon, C., Juillard, L., Dubourg, L. D., & Guebre‐Egziabher, F. (2016) · American Journal of Nephrology · doi:10.1159/000447365 · Cited by 25 · see citing works
LaGuardia, H., Hamm, L. L., & Chen, J. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/652608 · Cited by 24 · see citing works
Chang, A. R., Batch, B. C., McGuire, H. L., Vollmer, W. M., Svetkey, L. P., Tyson, C. C., Sanguankeo, A., Anderson, C. A. M., Houston, J., & Appel, L. J. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.04.022 · Cited by 24 · see citing works
Marková, I., Miklánková, D., Hüttl, M., Kačer, P., Skibová, J., Kucera, J., Sedláček, R., Kačerová, T., Kazdová, L., & Malínská, H. (2019) · Journal of Diabetes Research · doi:10.1155/2019/8712979 · Cited by 24 · see citing works
Kidney disease in patients with obesity: It is not always obesity-related glomerulopathy alone
Salvatore, S., Chevalier, J. M., Kuo, S., Audia, P. F., & Seshan, S. V. (2017) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2017.04.003 · Cited by 24 · see citing works
Yarnoff, B., Hoerger, T. J., Shrestha, S. S., Simpson, S. K., Burrows, N. R., Anderson, A. H., Xie, D., Chen, H., Pavkov, M. E., & the CRIC Study Investigators (2018) · PLoS ONE · doi:10.1371/journal.pone.0205530 · Cited by 23 · see citing works
Owusu, J., & Barrett, E. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147574 · Cited by 23 · see citing works
GLP-1 receptor agonists in diabetic kidney disease
Michos, E. D., & Tuttle, K. R. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.18771220 · Cited by 23 · see citing works
Min, S. H., Kim, S., Jeong, I., Cho, H., Jeong, J., Lee, J., Kang, H., Kim, H.-S., Park, K. S., & Lim, S. K. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0200 · Cited by 22 · see citing works
Oxalate nephropathy in systemic sclerosis: Case series and review of the literature
Ligon, C., Hummers, L. K., & McMahan, Z. H. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.06.017 · Cited by 20 · see citing works
Ramirez-Jimenez, M., Morales-Palomo, F., Moreno-Cabañas, A., Alvarez-Jimenez, L., Ortega, J., & Mora-Rodríguez, R. (2021) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/sms.13949 · Cited by 19 · see citing works
Fu, C.-P., Sheu, W., Lee, I., Lee, W.-J., Wang, J.-S., Liang, K.-W., Lee, W.-L., & Lin, S.-Y. (2015) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm-2014-0468 · Cited by 18 · see citing works
Eid, B. G., Neamatallah, T., Hanafy, A., El‐Bassossy, H. M., Binmahfouz, L. S., Aldawsari, H. M., Hasan, A., El-Aziz, G. S. A., Vemuri, K. V., & Makriyannis, A. (2021) · Molecules · doi:10.3390/molecules26040866 · Cited by 14 · see citing works
Koh, E. S., Han, K., Kim, M. K., Kim, E. S., Lee, M.-K., Nam, G. E., Hong, O., & Kwon, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-81396-0 · Cited by 12 · see citing works
Nilsson, P. M., Laurent, S., Cunha, P. M. G. M., Olsen, M. H., Rietzschel, E., Franco, O. H., Ryliškytė, L., Strazhesko, I., Vlachopoulos, C., Chen, C.-H., et al. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 11 · see citing works
Scurt, F. G., Kuczera, T., Mertens, P. R., & Chatzikyrkou, C. (2019) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0768-5899 · Cited by 9 · see citing works
Self-citationCorreia‐Costa, L., Morato, M., Sousa, T., Cosme, D., Guimarães, J. T., Guerra, A., Schaefer, F. S., Afonso, A. C., Azevedo, A., & Albino‐Teixeira, A. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3232-1 · Cited by 8 · see citing works
Early histological changes in the kidney of people with morbid obesity
Goumenos, D. S., Kawar, B., Nahas, M. E., Conti, S., Wagner, B., Spyropolous, C., Vlachojannis, J. G., Benigni, A., & Kalfarentzos, F. E. (2010) · Obesity and metabolism · doi:10.14341/2071-8713-5290 · Cited by 8 · see citing works
Stewart, L. K., Beam, D. M., Casciani, T., Cameron, S. J., & Kline, J. A. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.12.043 · Cited by 7 · see citing works
Scurt, F. G., Bose, K., Canbay, A. E., Mertens, P. R., & Chatzikyrkou, C. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1402-1502 · Cited by 4 · see citing works
Self-citationMiller, W. L. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.009344 · Cited by 2 · see citing works
Kann Allopurinol die Progression der chronischen Niereninsuffizienz verlangsamen?
Chatzikyrkou, C. (2020) · Der Nephrologe · doi:10.1007/s11560-020-00464-0 · Cited by 1 · see citing works
Self-citation
Flagged first, then by citations
3 of the 165 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Cardiovascular-kidney-metabolic syndrome – An integrative review
Kittelson, K. S., Gasparotto, A., Fillmore, N., & Gomes, R. D. S. (2024) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2024.10.012 · Cited by 102 · see citing works
Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches
Hamooya, B. M., Siame, L., Muchaili, L., Masenga, S. K., & Kirabo, A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1661603 · Cited by 88 · see citing works
Cao, Y., Wang, W., Xie, S., Xu, Y., & Lin, Z. (2025) · BMC Public Health · doi:10.1186/s12889-024-21131-2 · Cited by 81 · see citing works
Yu, W., Sun, S., Yan, Y., Zhou, H., Liu, Z., & Fu, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1519925 · Cited by 66 · see citing works
Giangregorio, F., Mosconi, E., Debellis, M. G., Provini, S., Esposito, C., Garolfi, M., Oraka, S., KALOUDI, O., Mustafazade, G., Marín‐Baselga, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195880 · Cited by 63 · see citing works
Li, M., Lin, H., Yang, Q., Zhang, X., Zhou, Q., Shi, J., & Ge, F. (2024) · SLEEP · doi:10.1093/sleep/zsae280 · Cited by 61 · see citing works
The Kidney in Obesity: Current Evidence, Perspectives and Controversies
Kounatidis, D. C., Vallianou, N. G., Stratigou, T., Voukali, M., Karampela, Ι., & Dalamaga, Μ. (2024) · Current Obesity Reports · doi:10.1007/s13679-024-00583-y · Cited by 51 · see citing works
Kanbay, M., Güldan, M., Özbek, L., Çöpür, S., Covic, A. S., & Covic, A. C. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.07.014 · Cited by 37 · see citing works
Dhurandhar, Y., Tomar, S., Das, A., Prajapati, J. L., Singh, A. K., Bodakhe, S. H., & Namdeo, K. P. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10509-z · Cited by 27 · see citing works
Tain, Y., & Hsu, C. (2024) · Antioxidants · doi:10.3390/antiox13020226 · Cited by 26 · see citing works
Dong, J., Yang, F., Xu, Y., Zhao, Q., Li, X., Liu, T., & Tang, Y. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c04950 · Cited by 17 · see citing works
Sakizlian, D. D. M., Boldeanu, L., Mitrea, A., Clenciu, D., Vladu, I. M., Plasiciuc, A. E. C., Șarla, A. V., Siloşi, I., Boldeanu, M. V., Assani, M.-Z., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136227 · Cited by 16 · see citing works
Metabolic Syndrome and Insulin Resistance in Romania
Ștefan, A. G., Clenciu, D., Mitrea, A., Vladu, I. M., Timofticiuc, D. C. P., Roşu, M. M., Maria, D. T., Dinu, R., Gheonea, T. C., Vladu, B. E., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062389 · Cited by 15 · see citing works
Huang, N., Lu, B., Zhu, Z.-Z., Zhu, X., Chen, S., Shu, Z.-Y., Liu, G.-F., Peng, Y., & Li, L. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s477836 · Cited by 13 · see citing works
Insulin resistance and hyperinsulinaemia in kidney disease: mechanisms and metabolic effects
Zaitoon, H., Abdul‐Ghani, M. A., & DeFronzo, R. A. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01066-0 · Cited by 12 · see citing works
Data-driven cluster analysis identifies distinct types of cardiovascular-kidney-metabolic syndrome
Yang, M., Su, C., Chang, X., Wang, G., & Liu, J. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf708 · Cited by 11 · see citing works
Li, F., Luo, Y., Li, X., Dai, Y., & Xiang, Q. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01532-4 · Cited by 9 · see citing works
Breastfeeding and Future Cardiovascular, Kidney, and Metabolic Health—A Narrative Review
Tain, Y., Lin, Y.-J., & Hsu, C. (2025) · Nutrients · doi:10.3390/nu17060995 · Cited by 9 · see citing works
Gut microbiota-derived SCFAs and MetS-related nephropathy
Tian, X., Sun, L., Guo, S., Yuan, L., Zhang, T., Huang, C., He, T., Jiang, Q., & Zeng, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1561271 · Cited by 9 · see citing works
Shen, N., Lu, S., Kong, Z., Gao, Y., Hu, J., Si, S., Wang, J., Li, J., Han, W., Wang, R., et al. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01386-w · Cited by 8 · see citing works
Zhu, L., Ruan, X., Wang, J., Yan, Y., Tang, C., & Xu, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1442274 · Cited by 8 · see citing works
Zhang, B., Chen, H., Yang, R., Jiang, Z., Huang, S., Chen, Z., Liu, C., Wang, L., & Liu, X. (2025) · FEBS Journal · doi:10.1111/febs.17414 · Cited by 8 · see citing works
Lezama, C. A. A., Ramos, J., Eguizábal, D. A. A., Ovando, X. S. S., Villagran, J., & Caiza, C. J. M. (2025) · Cureus · doi:10.7759/cureus.85813 · Cited by 8 · see citing works
Complement anaphylatoxins: Potential therapeutic target for diabetic kidney disease
Ma, J., Yiu, W. H., & Tang, S. C. W. (2024) · Diabetic Medicine · doi:10.1111/dme.15427 · Cited by 8 · see citing works
He, W., Wei, Z., Li, S., Han, S., Ma, J., Wu, L., Lu, D., & Ta, G. (2025) · Pharmaceutical Biology · doi:10.1080/13880209.2025.2543829 · Cited by 7 · see citing works
Kim, Y. J., Bae, Y. S., Chang, Y., & Shin, S. H. (2025) · Nutrients · doi:10.3390/nu17182986 · Cited by 7 · see citing works
Han, Z., Gong, L., Xue, Y., Wang, R., Liu, J., Wang, X., Zhao, W., Liao, H., & Li, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1426917 · Cited by 7 · see citing works
Gosav, E. M., Tănase, D. M., Ouatu, A., Buliga-Finiș, O. N., Popescu, D., Dascălu, C. G., Dima, N., Bădescu, M. C., & Rezuș, C. (2025) · Life · doi:10.3390/life15060960 · Cited by 7 · see citing works
Lin, D.-J., Hu, D.-X., Wu, Q., Huang, L.-G., Lin, Z.-H., Xu, J., He, X., & Wu, L. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1508381 · Cited by 6 · see citing works
Feng, C., Li, X., Fan, Z., Zhang, Z., & Di, J. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-099529 · Cited by 6 · see citing works
Wang, Y., Wang, Y., He, X., & Li, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1554637 · Cited by 11 · see citing works
Shui, K., Zhang, H., Li, T., Hou, J., Lan, G., Peng, F., Yu, S., Xie, X., Dai, H., & Peng, L. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04307-9 · Cited by 6 · see citing works
The burden of metabolic diseases in the Arab region, 1990–2021
Pan, Z., Fouad, Y., Abaalkhail, F., Hassani, A. A., Altarrah, M. Y., Derbala, M., Abdulla, M., Tahiri, M., Al-Busafi, S. A., Alkhalidi, N., et al. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251406531 · Cited by 6 · see citing works
Kachouei, A. A., Kamrani, F., Akhavan, N. S., & Haghighatdoost, F. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-00872-9 · Cited by 6 · see citing works
Guo, F.-S., Dou, J., Wang, J.-X., Guo, C. Y., Wu, R., Sun, X.-L., Hu, Y.-W., & Wei, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01671-2 · Cited by 5 · see citing works
Metabolic Syndrome Evolution and Cardio-Kidney-Metabolic Multimorbidity
Wang, Y., Chen, Z., Huo, Z., Qin, H., Fu, P., Wu, K., Zheng, H., Cai, Z., Wu, W., Lan, Y., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101778 · Cited by 7 · see citing works
Liu, Q., An, X.-F., Li, L., Zhang, H., & Zuo, Y.-Q. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s527662 · Cited by 5 · see citing works
Wen, S., Zhou, S., Wang, W., Qiu, X., & Feng, Y. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041978 · Cited by 5 · see citing works
Translational Lifestyle Medicine Approaches to Cardiovascular–Kidney–Metabolic Syndrome
Papadakis, Z. (2025) · Healthcare · doi:10.3390/healthcare14010051 · Cited by 4 · see citing works
Wei, X., Wei, J., Feng, J., Li, C., Zhang, Z., Hu, B., Long, N., & Luo, C. (2024) · European journal of medical research · doi:10.1186/s40001-024-01804-9 · Cited by 5 · see citing works
Haodong, Z., Cheng, J., Chen, J., Wang, Y., Liu, X., & Baoping, C. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2494043 · Cited by 5 · see citing works
El-Dis, G. R. A., Abdelazeez, W. M. A., Suliman, A. A., & Mohammed, D. M. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106795 · Cited by 6 · see citing works
Zhao, L., Zhao, C., Wang, Z., Chen, Z., Zheng, H., Ai, S., Tao, J., Li, D., Sun, W., & Wang, Y. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2508295 · Cited by 6 · see citing works
Emerging insights into the role of visceral adipose tissue in diabetic kidney disease
Li, L., Liu, C., & Gu, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1715701 · Cited by 4 · see citing works
Yang, G., Cheng, B., Shen, X., Ding, Y., Zhang, Y., Cheng, Q., Zheng, Y., & Zhao, J. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005137 · Cited by 4 · see citing works
Li, H., Wang, J., Zhang, T., Lou, P., Xu, L., & Ma, L. (2025) · BMC Public Health · doi:10.1186/s12889-025-24674-0 · Cited by 4 · see citing works
Pu, F., He, R., Wei, Y., Gong, J., Mu, D., Shi, L., & Hu, W. (2025) · Obesity Reviews · doi:10.1111/obr.70064 · Cited by 4 · see citing works
Kiyoyama, H., Tanabe, M., Higashi, M., Kamamura, N., Kawano, Y., Ihara, K., Hideura, K., & Ito, K. (2025) · Abdominal Radiology · doi:10.1007/s00261-025-04834-x · Cited by 4 · see citing works
Comparative proteomic analysis of renal tissue of normotensive and hypertensive rats
Бунеева, О. А., Fedchenko, V. I., Kaloshina, S. A., Zavialova, M. G., Zgoda, V. G., & Medvedev, A. E. (2024) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20247002089 · Cited by 4 · see citing works
Kong, M.-W., Yu, Y., Wan, Y., Gao, Y., & Zhang, C.-X. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i36.4036 · Cited by 4 · see citing works
Cai, X., Wang, D., Wang, J., Ding, C., Li, Y., Zheng, J., & Xue, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1392466 · Cited by 3 · see citing works
Zhang, F., & Li, W. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s516687 · Cited by 3 · see citing works
MicroRNAs in metabolic syndrome: Mechanisms, diagnosis, and therapy
Rahman, M. A., Islam, M. M., Islam, M. M., Ripon, M. A. R., & Hossain, M. S. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.06.003 · Cited by 3 · see citing works
Huang, S.-C., Yao, X., Chen, X.-Q., Chen, X., Li, Y.-X., Kanwar, Y., Chan, F., Ye, P., & Zhan, M. (2024) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s473299 · Cited by 4 · see citing works
Huang, Y., Fu, R., Zhang, J., Zhou, J., Chen, S., Lin, Z., Xie, X., & Hu, Z. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01958-5 · Cited by 3 · see citing works
Endocrine disorders linked to chronic kidney disease: Mechanisms and clinical implications
Concepción‐Zavaleta, M. J., Fuentes‐Mendoza, J. M., López-Ramírez, E. P., Martínez-García, J. A., Urteaga, L. A. C., & Paz‐Ibarra, J. (2026) · World Journal of Nephrology · doi:10.5527/wjn.v15.i1.113875 · Cited by 3 · see citing works
Wang, B., Zuo, L., Fan, J., Ji, Y., Xu, L., Xu, M. Q., An, Y., Zhang, Y., Ji, G., & Yu, D. (2024) · Insights into Imaging · doi:10.1186/s13244-024-01722-8 · Cited by 3 · see citing works
Association Between Metabolic Syndrome and the Size of Renal Cysts: A Cross-Sectional Study
Tao, B., Gu, D., Wang, K., Li, Y., Xu, X., & Chen, J. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s479665 · Cited by 3 · see citing works
Li, W., Chen, L., Jiang, L., Zhang, Z., & Song, K. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1589173 · Cited by 2 · see citing works
Association of predicted basal metabolic rate and insulin resistance in a Chinese general population
Wang, L., Lu, T., Wu, P., Chen, K., & Yi-ming, M. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01976-3 · Cited by 2 · see citing works
Xu, Y., Zhang, X., Fang, J., Xu, W., Chen, Q., Zhu, Y., Hu, H., Cao, X., & Zhang, X. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1652015 · Cited by 2 · see citing works
Chen, J., Yang, J., Lu, X., Peng, J., He, L., Tan, W., Yu, Q., & Wang, Y. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03248-5 · Cited by 2 · see citing works
Pu, F., He, R., Wei, Y., Li, J., Liao, X., Shi, L., & Hu, W. (2025) · British Journal Of Nutrition · doi:10.1017/s0007114525105801 · Cited by 2 · see citing works
Saad, K. M., Gad, M. S., Tang, J., Capehart, K. L., Abdelsayed, R. A., Williams, J. M., & Elmarakby, A. A. (2025) · Biomedicines · doi:10.3390/biomedicines13123105 · Cited by 2 · see citing works
Inflammatory Load Across Diabetes Duration: CRP and ESR Patterns and Their Metabolic Correlates
Brata, R. D., Vesa, C. M., Moisi, M. I., Ghitea, T. C., Pop, N. O., & Pantiș, C. (2026) · Metabolites · doi:10.3390/metabo16030202 · Cited by 2 · see citing works
Tain, Y., & Hsu, C. (2026) · Biomedical Journal · doi:10.1016/j.bj.2026.100970 · Cited by 2 · see citing works
Alkouri, O. A., Al-Qerem, W. A., Jarrah, M., Alharbi, G., Alrida, N. A., Alabkal, R. M., Hammoudeh, A. J., Abdelgawad, M. E., Alshehri, A., Hasan, A. Y., et al. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13060240 · Cited by 2 · see citing works
Soares, A. O., Loli, D. A. C., de Carvalho, G. R., Delfino, V. D. A., & Bignardi, P. R. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10059-0 · Cited by 2 · see citing works
The relationship between cardiometabolic Index and diabetic kidney disease in people with diabetes
Kong, J., Tao, W., Sun, Y., Xu, Y., Li, H., & Li, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1376813 · Cited by 2 · see citing works
Worldwide impact of disease attributable to low physical activity for diabetes and kidney diseases
Ding, P., Qi, L., Wang, J.-L., Tang, M., & Weng, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1499381 · Cited by 2 · see citing works
Guo, Q., Chen, M., Yu, Y., Li, P., Huang, X., Shen, L., Long, C., Liu, X., Lin, T., He, D., et al. (2024) · Pediatric Discovery · doi:10.1002/pdi3.93 · Cited by 1 · see citing works
Matsuoka‐Uchiyama, N., Uchida, H. A., Asakawa, T., Sakurabu, Y., Katayama, K., Okamoto, S., Onishi, Y., Tanaka, K., Takeuchi, H., Takemoto, R., et al. (2025) · Clinical and Experimental Nephrology · doi:10.1007/s10157-025-02640-9 · Cited by 1 · see citing works
Pajareya, P., Chuanchai, W., Siranart, N., Phutinart, S., Jansem, P., Basch, N., Techasatian, W., Tokavanich, N., Prasitlumkum, N., & Chokesuwattanaskul, R. (2025) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2025.0028 · Cited by 1 · see citing works
Sha, Y., Lu, J., Jin, R., Li, L., & Zhang, M. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s527941 · Cited by 1 · see citing works
Zeng, Z., & Xiao, Z. (2025) · BMC Public Health · doi:10.1186/s12889-025-23868-w · Cited by 1 · see citing works
Impactos da obesidade na função renal: uma análise das evidências
Cunha, P. A. R., Moreno, A. L., Alvim, A. L. S., & de Oliveira, A. A. S. B. (2025) · Journal Archives of Health · doi:10.46919/archv6n3-007 · Cited by 1 · see citing works
Lyu, Y. S., Yoon, Y., Kim, J. H., & Kim, S. Y. (2025) · Biomedicines · doi:10.3390/biomedicines13081886 · Cited by 1 · see citing works
Shi, L., Zhang, D., & Zhang, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1564368 · Cited by 1 · see citing works
The interplay of NAD+, hyperuricemia, and renal damage: A scientific review
Sánchez‐Lozada, L. G., García‐Arroyo, F. E., Gonzaga, G., Aparicio‐Trejo, O. E., Cuevas-López, B., Reyes-Leo, M., Rodríguez‐Iturbe, B., & Johnson, R. J. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156256 · Cited by 1 · see citing works
Peng, X., Chen, S., Wu, S., Ding, X., Wu, K., Huang, Z., Song, Q., Liu, Y., Zhao, M., Olsen, M. H., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041962 · Cited by 1 · see citing works
Yang, H., Huang, Y., Jiang, G., Guo, H., & Duan, Z. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01095-3 · Cited by 1 · see citing works
Gut dysbiosis in kidney injury: therapeutic potential of fecal microbiota transplantation
Liu, J., Ning, X., Yuan, J., Yu, Z., Qin, Y., Xing, Y., Zhao, J., & Sun, S. (2026) · European journal of medical research · doi:10.1186/s40001-026-04100-w · Cited by 1 · see citing works
Cherney, D. Z. I., Rossing, P. R., Canziani, M. E., Caramori, M. L., Correa‐Rotter, R., Cronin, L., Hugo, C., Ji, B., Meyerhoff, J., Nangaku, M., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70836 · Cited by 1 · see citing works
Metabolic Associated Chronic Kidney Disease
Sharma, S., Kalra, S., Kapoor, N., Anandh, U., Verma, H., & Haddiya, I. (2026) · Indian Journal of Nephrology · doi:10.25259/ijn_524_2025 · Cited by 1 · see citing works
Emerging roles of SIRT7 in metabolic homeostasis and related disorders
Yu, S., Rabiu, L., Zhu, W., & Tian, Y. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168343 · Cited by 1 · see citing works
Ren, L., Ju, F., Liu, S. J., Cai, Y., Gang, X., & Wang, G. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s476815 · Cited by 3 · see citing works
Zhou, H., Huang, H., Zhao, H., Pang, N., Huang, M., Ou, C., & Ming, L. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04440-7 · Cited by 1 · see citing works
Pecháňová, O., Bulkova, R., Vranková, S., Klimentova, J., Galandakova, Z., & Cebová, M. (2025) · Physiological Research · doi:10.33549/physiolres.935724 · Cited by 1 · see citing works
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM
Miller, M., Bhatt, D. L., Brinton, E. A., Jacobson, T. A., Steg, P. G., Ketchum, S. B., Pineda, A. L., Tardif, J.-C., & Ballantyne, C. M. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101387
Ren, J., Sun, X., Pei, H., Zhu, S., Zhang, Y., Wen, R., Zhang, X., Liu, J., & Ma, Y. (2023) · doi:10.2196/preprints.54849
Zeng, Z., & Xiao, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4212743/v1
Ersoy, A., Ersözen, M. E., Ersoy, C., & Sarandöl, E. (2024) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.1588548
Síndrome metabólico en el paciente renal. Revisión bibliográfica
Hurtado, A. J. M., Cuenca, C. M., Rodríguez, R. E., & Montero, R. C. (2024) · Enfermería Nefrológica · doi:10.37551/s2254-28842024029
Sharma, S., Sharma, A., & Tejpal, S. (2025) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.4.1.16
The possibility of surgical treatment of urolithiasis in patients with chronic kidney disease
Popov, S. V., Guseinov, R. G., Сивак, К. В., Lelyavina, Т. А., Bunenkov, N. S., & Beshtoev, A. H. (2025) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2025-29-1-35-45
Kavrakova, J. B., Bogdanska, J., Cekovska, S., Topuzovska, S., Labudovikj, D., Trajkovska, K. T., Kostovska, I., Ampova, H., Emin, M., Petkovska, L., et al. (2025) · Journal of Morphological Sciences · doi:10.55302/jms258126bk
Gambin, D. J., Dallepiane, F. G., Saraiva, L. M., Führ, M. C. S., Piovesan, F., Mirek, C., Carli, J. P. D., & Trentin, M. S. (2025) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2024.0144.r1.14042025
Metabolic Syndrome and Its Effects on the Reno-Vascular System
Balaji, N., Ayazo, C., & Umana, I. E. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1011526
Jansana, M. D. M., López, P. J. T., Miquel, J. J. G., López‐González, Á. A., Sbert, P. R., Busquets-Cortés, C., & Ramírez‐Manent, J. I. (2025) · Medical Sciences · doi:10.3390/medsci13030122
- Authors
- Scurt, F. G., Ganz, M. J., Herzog, C., Bose, K., Mertens, P. R., & Chatzikyrkou, C.
- Affiliations
- University Clinic for Nephrology and Hypertension, Diabetology and Endocrinology (DE)
- Klinikum Magdeburg (DE)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Scurt, Florian G.
- Venue
- Obesity Reviews
- Publisher
- Wiley
- Published
- 2023-10-02
- Volume
- 25
- Issue
- 1
- Pages
- e13649-e13649
- ISSN
- 1467-7881 (ISSN-L)
- 1467-789X
- OpenAlex
- W4387246542
- Cited by
- 155
- References
- 165
- Citations by year
- 2026: 50 · 2025: 75 · 2024: 29 · 2023: 1
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Obesity Reviews (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- metabolic syndrome, chronic kidney disease, obesity, diabetes mellitus, insulin resistance, microalbuminuria, endothelial dysfunction, oxidative stress, inflammation, end-stage renal disease, renal hemodynamics, renal metabolism, SGLT2 inhibitors, GLP-1 receptor agonists, renin-angiotensin system inhibitors
- MeSH terms
- Diabetes Mellitus, Humans, Insulin Resistance, Obesity, Metabolic Syndrome, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
